TRex Bio: Funding, Investors & Team (Sep 2026)
TRexBio is a discovery stage biotechnology company leveraging cutting-edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therapeutics for cancer and inflammatory diseases. Our powerful ‘deep biology’ discovery engine maps human tissue Treg behavior to disease processes, allowing us to identify and characterize novel targets for therapeutic intervention. Leveraging this platform, we are building a broad portfolio of novel therapies that modulate the immune system to restore human tissue immune homeostasis.
TRex Bio has raised $85.0M across 2 funding rounds on record, the most recent a Series A of $26.0M announced in Mar 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
TRex Bio Company Profile and Key Stats
Latest funding round on record: Mar 2022.
TRex Bio Funding Rounds
TRex Bio raised $59.0M in an undisclosed round announced in Jun 2021.
9 months later, a Series A of $26.0M was announced in Mar 2022.
TRex Bio Founders and Leadership Team
Contact details for the TRex Bio team: 1 of 1 has an email address on file.
Start 14-day free trial →TRex Bio Funding Compared to Other Biotechnology Startups
TRex Bio's latest round of $26.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like TRex Bio in Biotechnology and South San Francisco
Companies Similar to TRex Bio
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
TRex Bio Funding FAQs
What does TRex Bio do?
TRexBio is a discovery stage biotechnology company leveraging cutting-edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therapeutics for cancer and inflammatory diseases. Our powerful ‘deep biology’ discovery engine maps human tissue Treg behavior to disease processes, allowing us to identify and characterize novel targets for therapeutic intervention. Leveraging this platform, we are building a broad portfolio of novel therapies that modulate the immune system to restore human tissue immune homeostasis.
How much funding has TRex Bio raised?
TRex Bio has raised $85.0M across 2 rounds on record. The most recent is a Series A of $26.0M announced in Mar 2022.
When did TRex Bio last raise funding?
TRex Bio's most recent funding round on record is a Series A of $26.0M, announced in Mar 2022.
Who is the CEO of TRex Bio?
Johnston Erwin is listed as CEO at TRex Bio.
Where is TRex Bio headquartered?
TRex Bio is based in South San Francisco, California, United States.
How many employees does TRex Bio have?
TRex Bio is in the 11-50 employee band.
How does TRex Bio's funding compare to other Biotechnology startups?
TRex Bio's latest round of $26.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's TRex Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for TRex Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.